Charles N. York II
2016
In 2016, Charles N. York II earned a total compensation of $686.3K as Chief Financial Officer and Vice President at Aeglea BioTherapeutics, a 74% increase compared to previous year.
Compensation breakdown
| Bonus | $78,000 |
|---|---|
| Salary | $299,729 |
| Stock Awards | $301,019 |
| Other | $7,537 |
| Total | $686,284 |
York received $301K in stock awards, accounting for 44% of the total pay in 2016.
York also received $78K in bonus, $299.7K in salary and $7.5K in other compensation.
Rankings
In 2016, Charles N. York II's compensation ranked 9,969th out of 14,075 executives tracked by ExecPay. In other words, York earned more than 29.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,969 out of 14,075 | 29th |
Division Manufacturing | 3,847 out of 5,486 | 30th |
Major group Chemicals And Allied Products | 1,350 out of 1,900 | 29th |
Industry group Drugs | 1,077 out of 1,543 | 30th |
Industry Pharmaceutical Preparations | 844 out of 1,173 | 28th |
Source: SEC filing on April 21, 2017.
York's colleagues
We found two more compensation records of executives who worked with Charles N. York II at Aeglea BioTherapeutics in 2016.